Top Industry Leaders in the Women Health Disease Diagnosis Treatment Market
Roche Received FDA approval for Alnylam Pharmaceuticals' Onpattro™ (patisiran), the first-ever RNA interference (RNAi) therapy for the treatment of hereditary transthyretin amyloidosis (hATTR), a rare genetic condition affecting women more than men.
Hologic Launched the Genius™ 3D Mammography™ Examination System, featuring advanced breast cancer detection capabilities with improved image clarity and reduced radiation dose.
Abbott Unveiled the FreeStyle Libre 3 Sensor, a continuous glucose monitoring system that eliminates the need for finger pricking and empowers women with diabetes to better manage their condition.
Johnson & Johnson Acquired Abiomed, a medical technology company specializing in heart pumps, strengthening its presence in the cardiovascular market with solutions catering to women with heart disease.
Illumina Partnered with the Broad Institute of MIT and Harvard to develop a comprehensive genetic test for women's health, aiming to identify risks for various diseases and guide preventive measures.
List of Women Health Disease Diagnosis & Treatment Key Companies in the Market
- General Electric Company (UK)
- CooperSurgical Inc. (US)
- ASCEND Therapeutics US LLC. (US)
- Rinovum Women's Health LLC. (US)